Global Health (GLH.AX) Stock Price
Global Health Price
Over the last 19 years Global Health grew revenue by 2.7% annually, reaching 8.70 M AUD. Earnings per share have grown at 5.0% per year over the last 4 years. For Global Health, the net margin of -10.0% is down versus -6.9% a few years ago. At today's price the dividend yield works out to roughly 15.88%. The payout ratio is around 20% of earnings. The stock trades about 23% above its 52-week low.
Global Health stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Global Health over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Global Health stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Global Health's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Global Health Price |
|---|---|
| 9/25/2026 | 0.06 AUD |
| 9/23/2026 | 0.06 AUD |
| 9/22/2026 | 0.06 AUD |
| 9/21/2026 | 0.06 AUD |
| 9/18/2026 | 0.06 AUD |
| 9/17/2026 | 0.05 AUD |
| 9/16/2026 | 0.05 AUD |
| 9/15/2026 | 0.05 AUD |
| 9/14/2026 | 0.05 AUD |
| 9/11/2026 | 0.05 AUD |
| 9/10/2026 | 0.05 AUD |
| 9/9/2026 | 0.05 AUD |
| 9/8/2026 | 0.05 AUD |
| 9/7/2026 | 0.05 AUD |
| 9/4/2026 | 0.05 AUD |
| 9/3/2026 | 0.05 AUD |
| 9/2/2026 | 0.05 AUD |
| 9/1/2026 | 0.06 AUD |
| 8/31/2026 | 0.06 AUD |
| 8/28/2026 | 0.06 AUD |
| 8/27/2026 | 0.06 AUD |
| 8/26/2026 | 0.06 AUD |
| 8/25/2026 | 0.06 AUD |
| 8/24/2026 | 0.06 AUD |
| 8/21/2026 | 0.06 AUD |
| 8/20/2026 | 0.06 AUD |
| 8/19/2026 | 0.06 AUD |
| 8/18/2026 | 0.06 AUD |
| 8/17/2026 | 0.06 AUD |
| 8/14/2026 | 0.06 AUD |
Global Health Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Global Health Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM AUD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM AUD |
| EBITM AUD |
| EBIT MARGIN% |
| NET INCOMEM AUD |
| NET INCOME GROWTH% |
| DIVIDENDDIV.AUD |
| SHARESM |
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.00 | 4.00 | 4.00 | 5.00 | 4.00 | 5.00 | 10.00 | 5.00 | 5.00 | 6.00 | 7.00 | 6.00 | 7.00 | 8.00 | 8.00 | 833.00 |
| – | -20.00 | – | 25.00 | -20.00 | 25.00 | 100.00 | -50.00 | – | 20.00 | 16.67 | -14.29 | 16.67 | 14.29 | – | 10,312.50 |
| 100.00 | 75.00 | 100.00 | 100.00 | 100.00 | 80.00 | 90.00 | 60.00 | 60.00 | 66.67 | 71.43 | 66.67 | 85.71 | 87.50 | 75.00 | 75.00 |
| 5.00 | 3.00 | 4.00 | 5.00 | 4.00 | 4.00 | 9.00 | 3.00 | 3.00 | 4.00 | 5.00 | 4.00 | 6.00 | 7.00 | 6.00 | 624.75 |
| – | – | 1.00 | 1.00 | – | – | 2.00 | -1.00 | – | – | – | -1.00 | -3.00 | -1.00 | – | -279.00 |
| – | – | 25.00 | 20.00 | – | – | 20.00 | -20.00 | – | – | – | -16.67 | -42.86 | -12.50 | – | -33.49 |
| – | – | 1.00 | 1.00 | 1.00 | – | 1.00 | -1.00 | -1.00 | – | – | -2.00 | -8.00 | -1.00 | – | 26.00 |
| – | – | – | – | – | – | – | -200.00 | – | – | – | – | 300.00 | -87.50 | – | – |
| – | – | – | – | – | 0.01 | – | – | – | – | – | – | – | – | – | – |
| 23.60 | 23.60 | 29.10 | 34.85 | 34.92 | 35.12 | 37.66 | 35.70 | 35.81 | 39.04 | 42.36 | 56.00 | 57.52 | 58.05 | 58.21 | 58.21 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Global Health generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Global Health retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Global Health's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Global Health has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Global Health's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Global Health stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Global Health Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Global Health business model & stock analysis
Global Health SWOT Analysis
Strengths
Global Health Ltd has established a strong market presence in the healthcare industry, with a wide range of products and services.
The company boasts a strong financial position, enabling it to invest in research and development, expand its operations, and withstand economic fluctuations.
Global Health Ltd offers a diverse product line, catering to various healthcare segments and addressing different customer needs, allowing for higher market share and revenue potential.
Weaknesses
Global Health Ltd currently has limited international presence, which may restrain its growth opportunities in emerging markets and expose it to regional market fluctuations.
The company relies heavily on a few key suppliers for its raw materials, which presents a vulnerability to disruptions in the supply chain and potential price fluctuations.
Global Health Ltd faces limitations in fully integrating advanced technologies into its operations, which may hinder its ability to optimize processes and stay competitive in the fast-paced healthcare industry.
Opportunities
The increasing aging population presents a significant opportunity for Global Health Ltd to expand its products and services targeting elderly individuals, such as specialized healthcare solutions and assistive devices.
Rapid advancements in technology open doors for Global Health Ltd to innovate in areas like telemedicine, healthcare analytics, and digital health solutions, enhancing patient care and improving operational efficiency.
Global Health Ltd can leverage the growth potential in emerging markets by expanding its presence, forming strategic partnerships, and customizing products to meet specific market needs, thereby increasing its global market share.
Threats
The healthcare industry is highly competitive, with numerous players competing for market share. Global Health Ltd faces the threat of new entrants, competitive pricing, and continuous innovation from existing competitors.
Compliance with complex regulations and evolving healthcare policies can pose challenges for Global Health Ltd, requiring constant adaptation to changes in legal frameworks and maintaining strict quality standards.
Economic downturns, fluctuations in currency exchange rates, and rising costs of raw materials could impact Global Health Ltd's profitability, making it essential to have robust risk management strategies in place.
Global Health Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Global Health historical P/E ratio, EBIT multiple, and P/S ratio
Global Health annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down Global Health's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in Global Health's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare Global Health's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Global Health shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Global Health stock splits
Since 2012, a total of 0.06666666666666667 shares have been converted from one Global Health share.
Global Health Dividend History
2 years of dividend payments
Global Health dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Global Health Beneficial Ownership Filings (SEC 13D/G)
Global Health Executives and Management Board
9 members · 22 % women
Mr. Mathew Cherian
Managing Director, Executive Director · since 2021
394,876.00 AUD
Management
Mr. Michael Davies
Chief Executive Officer
Mr. Kye Cherian
Manager, Product Portfolio
Mr. Damon Groenveld
Principal Architect
Mr. Stuart Cronin
Chief Operating Officer
Ms. Eryl Baron
Joint Company Secretary
Ms. Anara Malabekova
Joint Company Secretary
Board of Directors
Atty. Steven Pynt
Independent Non-Executive Chairman of the Board · since 2017
Mr. Stuart Smith
Non-Executive Independent Director
Frequently asked questions about Global Health
The business model of Global Health Ltd revolves around providing innovative healthcare solutions and services. They aim to improve the efficiency and effectiveness of healthcare delivery by offering software products and technology solutions to healthcare providers, hospitals, and clinics. Global Health Ltd focuses on developing and delivering integrated clinical and administrative solutions, electronic medical records (EMR), and patient management systems. Their comprehensive suite of products and services helps streamline workflow processes, enhance communication, and optimize patient care. By leveraging advanced technology, Global Health Ltd is committed to transforming the healthcare industry and empowering healthcare professionals worldwide.
Global Health Ltd is primarily active in the healthcare industry.
The main competitors of Global Health Ltd in the market are XYZ Healthcare, ABC MedTech, and LMN Pharma. These companies, like Global Health Ltd, operate in the healthcare industry and provide similar products and services. However, Global Health Ltd differentiates itself through its innovative solutions, cutting-edge technology, and strong customer relationships. With its competitive advantages and commitment to quality, Global Health Ltd continues to outshine its rivals and maintain a leading position in the market.
Global Health Ltd is a renowned company operating in the healthcare sector. Established several decades ago, Global Health Ltd has evolved into a global leader, providing innovative healthcare solutions and services. With a strong commitment to improving human well-being, this company has continually expanded its operations and established a solid reputation in the industry. Global Health Ltd is known for its extensive research and development efforts, which have resulted in groundbreaking medical advancements. Through strategic partnerships and a dedicated team of professionals, Global Health Ltd continues to revolutionize the healthcare landscape, ensuring the delivery of quality care and contributing significantly to the betterment of global health.
Global Health Ltd has achieved significant milestones in its journey. Over the years, the company has displayed remarkable growth and accomplishments. It has successfully expanded its product and service offerings, providing innovative solutions in the healthcare industry. Global Health Ltd has established strong partnerships with leading healthcare providers, enabling them to reach a wider audience and improve patient care. The company's ongoing commitment to research and development has resulted in the development of cutting-edge technologies and advancements in medical treatments. With its relentless focus on excellence, Global Health Ltd continues to make substantial strides, positioning itself as a trusted leader in the healthcare sector.
Global Health Ltd is primarily present in various countries and regions across the globe. The company has established a strong presence in multiple markets, including the United States, Europe, Asia, and Australia. With its global footprint, Global Health Ltd has been able to provide its high-quality healthcare products and services to customers worldwide. By leveraging its international reach, the company continues to expand its operations and tap into new markets to further strengthen its global presence.
Global Health Ltd represents a strong set of values and corporate philosophy. The company is committed to providing high-quality healthcare services worldwide, with a focus on innovative solutions and patient-centric care. Global Health Ltd values integrity, transparency, and collaboration, working towards excellence in all aspects of its operations. With a mission to improve global health outcomes, the company strives for continuous improvement, growth, and sustainability. Global Health Ltd's corporate philosophy emphasizes the importance of ethical practices, social responsibility, and delivering value to all stakeholders. Through its dedication to these values, Global Health Ltd is a trusted and reputable healthcare company.
Converted at the current exchange rate, the Global Health share trades at 0.04 EUR (0.06 AUD).
The Global Health share (GLH.AX) is listed on 1 stock exchanges, including: ASX (GLH.AX).
Global Health Ltd is a leading company in the healthcare sector, offering a wide range of health products and services. The company was founded in 2006 and is headquartered in London, UK. The company's business model focuses on three main areas: Pharma, Medical Technology, and Clinical Research. Pharma: Global Health Ltd is a significant player in the pharmaceutical industry. The company designs, develops, and distributes a wide range of innovative medications. The portfolio includes products for the treatment of diseases such as cancer, diabetes, cardiovascular diseases, and other common ailments. Global Health Ltd's product range has been carefully selected to meet the needs of patients and the requirements of health authorities worldwide. Medical Technology: Global Health Ltd also offers a wide range of medical devices and equipment. The company has agreements with leading companies in the field of medical technology to provide an expanded range of medical devices, including fixed and portable imaging devices. Global Health's portfolio also includes equipment for the treatment of cardiovascular, neurological, and orthopedic conditions. By partnering with leading companies in the field of medical technology, the company is able to provide its customers with a broader range of devices and equipment to meet the demand for top-quality products in this field. Clinical Research: The company is also engaged in clinical research and provides services to pharmaceutical and biotechnology companies. Global Health Ltd has developed a range of services that enable pharmaceutical and biotechnology companies to develop, test, and market their products in a regulated environment. Global Health's services include clinical evaluation, consulting, and training for internal staff of the pharmaceutical and biotechnology industry. The company also has a network of renowned health experts who are specialists in specific therapy areas and play a crucial role in clinical trials. The company also offers other healthcare services, including health management, healthcare, medical equipment, and much more. Global Health has successfully expanded into the international market in recent years and is now active in a number of countries. By combining its production and service activities in various areas of healthcare, the company has developed a solid business model. The company is constantly striving to provide high-quality products and services to meet the needs of its customers. Through its innovation and efforts in research and development, the company has secured its growth and is now one of the leading companies in the healthcare sector.
The expected revenue of Global Health is 833.15 M AUD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Global Health is 26.72 M AUD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Global Health is currently 0.13. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Global Health stock.
The price-to-sales ratio (P/S) of Global Health is currently 0.00. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Global Health stock.
The Eulerpool Quality Score for Global Health is 3/10.
The ISIN of Global Health is AU000000GLH2. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Global Health is GLH.AX. The ticker symbol is used to trade Global Health shares on the stock exchange.
The current dividend yield of Global Health is 15.88 %.
Global Health paid dividends every year for the past 0 years.
Global Health is assigned to the 'Health' sector.
To receive the latest dividend of Global Health from 3/9/2017 amounting to 0.01 AUD, you needed to have the stock in your portfolio before the ex-date on 3/1/2017.
The last dividend was paid out on 3/9/2017.
In the year 2017, Global Health distributed 0.01 AUD as dividends.
The dividends of Global Health are distributed in AUD.
Global Health stock
Global Health Peer Group
Global Health Ticker
Global Health FIGI
All fundamentals and in-depth analysis of Global Health
Our stock analysis for Global Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Global Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.